ArticlePLOS digital health2026
Large language models enable prognostic stratification of cancer patients using real-world clinical notes.
Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In medical documentation, vast amounts of unstructured text are generated that are still underutilized in current prognostic models. We investigate the potential of self-hosted large language models (LLM) to extract clinically meaningful, patient-specific information from routine clinical notes for personalized risk stratification in cancer care. We collected real-world medical notes from 2,708 non-small cell lung cancer (NSCLC) patients and 814 colon cancer patients documented before treatment at a large comprehensive cancer center. LLMs extracted key prognostic indicators, including comorbidities, metastatic sites, and qualitative descriptors of patient condition, in a zero-shot manner without prior task-specific training. Integrating these LLM-derived features into machine learning models significantly improved the prediction of overall survival compared to TNM staging alone (C-Index: NSCLC, 0.72 vs 0.64; colon cancer, 0.70 vs 0.59), and surpassed models using text embeddings. Based on the LLM-informed risk scores, patients were stratified into four distinct risk groups, enabling reclassification of 61.4% of NSCLC and 68.3% of colon cancer patients. Analysis of model drivers revealed that LLM-derived factors, such as the physical condition, substantially modulated the prognostic impact of TNM stage. These findings highlight the potential of self-hosted LLM to derive prognostically relevant information from unstructured clinical documentation and support clinical decision-making.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.